SEC FORM 3 SEC Form 3
FORM 3 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0104
Estimated average burden
hours per response: 0.5
1. Name and Address of Reporting Person*
Meggs Jason M.

(Last) (First) (Middle)
C/O SYNEOS HEALTH, INC.
3201 BEECHLEAF COURT, SUITE 600

(Street)
RALEIGH NC 27604

(City) (State) (Zip)
2. Date of Event Requiring Statement (Month/Day/Year)
02/21/2018
3. Issuer Name and Ticker or Trading Symbol
Syneos Health, Inc. [ SYNH ]
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
EVP and Interim CFO
5. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5)
Class A Common Stock 34,797(1) D
Table II - Derivative Securities Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4) 2. Date Exercisable and Expiration Date (Month/Day/Year) 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 6. Nature of Indirect Beneficial Ownership (Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares
Stock Option (Right to Buy Class A Common Stock) (2) 07/29/2025 Class A Common Stock 2,108 43.16 D
Stock Option (Right to Buy Class A Common Stock) (3) 01/19/2026 Class A Common Stock 2,600 42.88 D
Stock Option (Right to Buy Class A Common Stock) (4) 11/01/2026 Class A Common Stock 620 46 D
Explanation of Responses:
1. Includes (i) 1,054 shares of restricted stock units ("RSUs") that vest 527 shares on each of July 29, 2018 and July 29, 2019; (ii) 866 shares of RSUs that vest 433 shares on each of January 19, 2019 and January 19, 2020; (iii) 232 shares of RSUs that vest 78 shares on November 1, 2018 and 77 shares on each of November 1, 2019 and November 2, 2020; (iv) 2,555 shares of RSUs that vest 1,278 shares on January 27, 2019 and 1,277 shares on January 27, 2020; and (v) 26,490 shares of RSUs that vest 8,830 shares on each of February 15, 2019, 2020 and 2021, subject to continued employment.
2. The shares subject to this option vest in four equal annual installments beginning on July 29, 2016 subject to continued employment.
3. The shares subject to this option vest in four equal annual installments beginning on January 19, 2017 subject to continue employment.
4. The shares subject to this option vest in four equal annual installments beginning on November 1, 2017 subject to continued employment.
Remarks:
/s/ Donald R. Reynolds, Attorney-in-Fact 03/02/2018
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
POWER OF ATTORNEY

    Known all by these presents, that the undersigned hereby constitutes and appoints each of  Purvesh D. Patel and Donald R. Reynolds, and each of them acting alone, signing singly, the undersigned's true and lawful attorney-in-fact to:  (1) execute for and on behalf of the undersigned, in the undersigned's capacity as an officer, director and/or 10% or more stockholder of INC Research Holdings, Inc. (the "Company"), Forms ID, 3, 4, 5 and Update Passphrase Acknowledgement  (and any amendments thereto) in accordance with Section 16(a) of the Securities Exchange Act of 1934, as amended (the "1934 Act"), and the rules promulgated thereunder; (2) do and perform any and all acts for and on behalf of the undersigned which may be necessary or desirable to complete and execute any such Form ID, 3, 4, 5 and Update Passphrase Acknowledgement (and any amendments thereto) and to file timely such form with the United States Securities and Exchange Commission and any stock exchange or similar authority; and (3) take any other action of any type whatsoever in connection with the foregoing which in the opinion of such attorney-in-fact may be of benefit to, in the best interest of, or legally required by, the undersigned, it being understood that
 the documents executed by such attorney-in-fact on behalf of the undersigned pursuant to this Power of Attorney shall be in such form and shall contain such terms and conditions as such attorney-in-fact may approve in such attorney-in-fact's discretion.

    The undersigned hereby grants to each such attorney-in-fact full power and authority to do and perform any and every act and thing whatsoever requisite, necessary or proper to be done in the exercise of any of the rights and powers herein granted, as fully to all intents and purposes as the undersigned might or could do if personally present, with full power of substitution or revocation, hereby ratifying and confirming all that such attorney-in-fact, or such attorney-in-fact's substitute or substitutes, shall lawfully do or cause to be done by virtue of this power of attorney and the rights and powers herein granted.  The undersigned acknowledges that the foregoing attorneys-in-fact, in serving in such capacity at the request of the undersigned, are not assuming, nor is the Company assuming, any of the undersigned's responsibilities to comply with Section 16 of the 1934 Act.

    This Power of Attorney shall remain in full force and effect until the undersigned is no longer required to file Forms ID, 3, 4 and 5 with respect to the undersigned's holdings of and transactions in securities issued by the Company, unless earlier revoked by the undersigned in a signed writing delivered to each of the foregoing attorneys-in-fact.  

    IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be executed as of this 26th day of February 2018.



                        /s/ Jason Meggs
                        Jason Meggs